Allergan has long dominated the anti-wrinkle arena with its Botox product, but it appears cosmo-pharma giant Johnson & Johnson is preparing to offer serious competition, with the development of its latest drug.
The FDA has agreed to evaluate an anti-wrinkle injection treatment
from France-based pharmaceutical company Ipsen which if approved
would provide a rival for Allergan's Botox.